EPIZYME, INC. Operating Lease Liability
EPIZYME, INC. had Operating Lease Liability of $20.83 million as of 2022-03-31, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-08-09
- 2022-03-31: Operating Lease, Liability $20.83M; Operating Lease, Liability as first filed $21.94M.
- 2021-12-31: Operating Lease, Liability $22.65M.
- 2021-09-30: Operating Lease, Liability $23.69M.
- 2021-06-30: Operating Lease, Liability $17.76M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2022-03-31 | $20.83M 10-Q · filed 2022-08-09 | $21.94M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $22.65M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $23.69M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $17.76M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $18.95M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $20.07M 10-K · filed 2021-02-23 | |
| 2020-09-30 | $21.06M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $21.56M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $22.00M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $22.16M 10-K · filed 2020-02-27 | |
| 2019-09-30 | $10.15M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $10.83M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $11.46M 10-Q · filed 2019-05-06 |